Skip to product information
1 of 1

ipx 203

ipx 203

IPX203 : What is it and is it FDA approved? ipx 203 Amneal Pharmaceuticals announced positive results yesterday from a pivotal Phase III clinical trial that evaluated IPX-203 in patients with ipx992 IPX-203 is a novel oral formulation of extended-release carbidopalevodopa capsules designed for patients with PD who experience motor fluctuations

ipx 564 IPX-203 is a carbidopa-levodopa treatment for patients with Parkinson's disease and an investigational product not approved by FDA

Regular price 126.00 ₹ INR
Regular price Sale price 126.00 ₹ INR
Sale Sold out
View full details